Yuto Hibino

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Fertility preservation and treatment outcomes in female patients with chronic-phase chronic myeloid leukemia: a single-institution experience

Fertility preservation and treatment outcomes in female patients with chronic-phase chronic myeloid leukemia: a single-institution experience

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 29, 2026

Poor outcome of older patients with diffuse large B-cell lymphoma after progression.

Poor outcome of older patients with diffuse large B-cell lymphoma after progression.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 30, 2025

Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma.

Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: March 16, 2025

Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma.

Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma.

Journal: Hematological oncology

Published: February 10, 2025

Clinical applicability of the ELN2020 criteria for tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia: insights from a multicenter retrospective study in real-world practice.

Clinical applicability of the ELN2020 criteria for tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia: insights from a multicenter retrospective study in real-world practice.

Journal: Leukemia research

Published: November 30, 2024

Factors Predicting Spontaneous Regression in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Diseases.

Factors Predicting Spontaneous Regression in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Diseases.

Journal: Clinical lymphoma, myeloma & leukemia

Published: November 30, 2024

Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report.

Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report.

Journal: Cancer reports (Hoboken, N.J.)

Published: May 10, 2024

SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment.

SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment.

Journal: International cancer conference journal

Published: February 26, 2024

Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.

Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.

Journal: International journal of hematology

Published: July 10, 2023

Successful treatment with lenalidomide for relapsed adult T-cell leukemia/lymphoma after cord blood cell transplantation.

Successful treatment with lenalidomide for relapsed adult T-cell leukemia/lymphoma after cord blood cell transplantation.

Journal: Blood cell therapy

Published: November 25, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026